First night efficacy of pramipexole in restless legs syndrome and periodic leg movements

Sleep Medicine

Volumn 8, Issue 5, 2007, Pages 491-497

  Manconi, Mauro ^a   Ferri, Raffaele ^b   Zucconi, Marco ^a   Oldani, Alessandro ^a   Fantini, Maria Livia ^a   Castronovo, Vincenza ^a   Ferini Strambi, Luigi ^a  

^a Scientific Institute   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Dopamine; On demand Therapy; Periodic leg movements; Pramipexole; Restless legs syndrome; Sleep

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; PRAMIPEXOLE;

ADULT; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LEG MOVEMENT; LOW DRUG DOSE; MALE; NEUROLOGIC EXAMINATION; PATHOGENESIS; PATIENT SELECTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE;

ADULT; AGED; BENZOTHIAZOLES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SLEEP STAGES; TREATMENT OUTCOME;

EID: 34347226324     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.10.008     Document Type: Article

References (30)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
2. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10 (1995) 634-642
3. Thorpy M.J. New paradigms in the treatment of restless legs syndrome. Neurology 64 (2005) S28-S33
4. Allen R.P., and Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19 (1996) 205-213
5. Walters A.S., Hening W.A., Kavey N., Chokroverty S., and Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24 (1988) 455-458
6. Ondo W., Romanyshyn J., Vuong K.D., and Lai D. Long-term treatment of restless legs syndrome with dopamine agonists. Arch Neurol 61 (2004) 1393-1397
7. Allen R., Becker P.M., Bogan R., Schmidt M., Kushida C.A., Fry J.M., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 (2004) 907-914
8. Manconi M., Casetta I., Govoni V., Cesnik E., Ferini-Strambi L., and Granieri E. Pramipexole in Restless Legs syndrome. Evaluation by suggested immobilization test. J Neurol 250 (2003) 1494-1495
9. Saletu M., Anderer P., Saletu B., Hauer C., Mandl M., Oberndorfer S., et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41 (2000) 190-199
10. Saletu M., Anderer P., Saletu-Zyhlarz G., Hauer C., and Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci 252 (2002) 185-194
11. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
12. Wewers M.E., and Lowe N.K. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13 (1990) 227-236
13. American Sleep Disorders Association. Recording and scoring leg movements. The atlas task force. Sleep 16 (1993) 748-759
14. Kemp B., Varri A., Rosa A.C., Nielsen K.D., and Gade J. A simple format for exchange of digitized polygraphic recordings. Electroencephalogr Clin Neurophysiol 82 (1992) 391-393
15. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington Public Health service. Washington: US Government Printing Office; 1968.
16. Ferri R., Zucconi M., Manconi M., Bruni O., Miano S., Plazzi G., et al. Computer-assisted detection of nocturnal leg motor activity in patients with restless legs syndrome and periodic leg movements during sleep. Sleep 28 (2005) 998-1004
17. Trenkwalder C., and Paulus W. Why do restless legs occur at rest? - Pathophysiology of neuronal structures in RLS Neurophysiology of RLS (part 2). Clin Neurophysiol 115 (2004) 1975-1988
18. Garcia-Borreguero D., Larrosa O., de la L.Y., Granizo J.J., and Allen R. Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med 5 (2004) 561-565
19. Allen R.P., and Earley C.J. Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2 (2001) 239-242
20. Montplaisir J., Lorrain D., and Godbout R. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol 31 (1991) 41-43
21. Piercey M.F. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clin Neuropharmacol 21 (1998) 141-151
22. Sautel F., Griffon N., Levesque D., Pilon C., Schwartz J.C., and Sokoloff P. A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 6 (1995) 329-332
23. Austin J. Schizophrenia: an update and review. J Genet Couns 14 (2005) 329-340
24. Bordet R. Central dopamine receptors: general considerations (Part 1). Rev Neurol (Paris) 160 (2004) 862-870
25. Nieoullon A., and Amalric M. Dopaminergic receptors: structural features and functional implications. Rev Neurol (Paris) 158 (2002) Spec no 1
26. Levant B., and McCarson K.E. D(3) dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci Lett 303 (2001) 9-12
27. Ondo W.G., He Y., Rajasekaran S., and Le W.D. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 15 (2000) 154-158
28. Silber M.H., Ehrenberg B.L., Allen R.P., Buchfuhrer M.J., Earley C.J., Hening W.A., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 79 (2004) 916-922
29. Tribl G.G., Sycha T., Kotzailias N., Zeitlhofer J., and Auff E. Apomorphine in idiopathic restless legs syndrome: an exploratory study. J Neurol Neurosurg Psychiatry 76 (2005) 181-185
30. Montplaisir J., Boucher S., Nicolas A., Lesperance P., Gosselin A., Rompre P., et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 13 (1998) 324-329